Progress in Molecular Targeted Therapy for Thyroid Cancer: Vandetanib in Medullary Thyroid Cancer

被引:12
|
作者
Solomon, Benjamin [1 ]
Rischin, Danny [1 ]
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
关键词
RET PROTOONCOGENE MUTATIONS; PHASE-II; PAPILLARY CARCINOMAS; ONCOGENE; INHIBITOR; AXITINIB; IMPACT;
D O I
10.1200/JCO.2011.37.8638
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:119 / 121
页数:3
相关论文
共 50 条
  • [1] VANDETANIB THERAPY IN MEDULLARY THYROID CANCER
    Grabowski, P.
    Briest, F.
    Baum, R. P.
    Zaknun, J. J.
    Kulkarni, H. R.
    Zeitz, M.
    Hoersch, D.
    [J]. DRUGS OF TODAY, 2012, 48 (11) : 723 - 733
  • [2] Vandetanib In Medullary Thyroid Cancer
    Frampton, James E.
    [J]. DRUGS, 2012, 72 (10) : 1423 - 1436
  • [3] Use of vandetanib in medullary thyroid cancer
    Marquez Fernandez, E.
    Marmesat Rodas, B.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 587 - 587
  • [4] Vandetanib (Caprelsa) for Medullary Thyroid Cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1381): : 3 - 4
  • [5] Vandetanib for the Treatment of Medullary Thyroid Cancer
    Chau, Nicole G.
    Haddad, Robert I.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (03) : 524 - 529
  • [6] Vandetanib: A novel targeted therapy for the treatment of metastatic or locally advanced medullary thyroid cancer
    Ton, GiangThy N.
    Banaszynski, Megan E.
    Kolesar, Jill M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (10) : 849 - 855
  • [7] Combination Therapy of Medullary Thyroid Cancer Using Radiation and Vandetanib
    Sandblom, V.
    Spetz, J.
    Shubbar, E.
    Swanpalmer, J.
    Forssell-Aronsson, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S768 - S768
  • [8] Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
    Degrauwe, Nils
    Sosa, Julie Ann
    Roman, Sanziana
    Deshpande, Hari A.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [9] Role of vandetanib in the management of medullary thyroid cancer
    Brassard, Maryse
    Rondeau, Genevieve
    [J]. BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 59 - 66
  • [10] Vandetanib in progressive and symptomatic medullary thyroid cancer
    Hartmann, Milan
    Faust, Michael
    Chiapponi, Costanza
    Alakus, Hakan
    Bruns, Christiane J.
    [J]. ONKOLOGE, 2020, 26 (12): : 1172 - 1174